newsfilter
← Latest News
ClinicalTrials.gov·

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer - NCT05501665

Incidence of adverse events, Best overall response rate, Progression free survival (PFS), (and 3 more...)